全球坏疽治疗市场 – 行业趋势和 2029 年预测

坏疽治疗市场分析和规模

坏疽治疗市场预计将在预测期内出现显着增长。根据世界卫生组织 (WHO) 的数据，糖尿病是导致失明、中风和下肢截肢的主要原因。2019 年，糖尿病导致 150 万人死亡。随着极端创伤发生率的增加，气性坏疽的风险也随之增加，从而导致坏疽市场的增长。COVID-19 疫情的突然爆发导致全球实施了严格的封锁规定，导致坏疽治疗市场的进出口活动中断。

Data Bridge Market Research 分析了 2022-2029 年预测期内全球坏疽治疗市场的增长率。在上述预测期内，全球坏疽治疗市场的预期复合年增长率往往约为 6.50%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

坏疽治疗市场范围和细分

Market Definition

Gangrene is a type of condition wherein the body tissues die because of either serious bacterial infection or the lack of blood flow. The cause for the extreme loss of blood supply could be an injury, underlying illness or infection. This disease prevalence is rising and essential diagnostic procedures and treatments will boost the growth of the market.

Global Gangrene Treatment Market Dynamics

Drivers

• Increase in Smoking and Lifestyle Changes

Cigarette smoking is one of the leading causes of preventable disease and death in the U.S. It  accounts for more than 480,000 deaths every year. In addition to this, the lifestyle changes that are attained by today’s population such as unhealthy lifestyle, poor diet, stress and many such factors altogether contribute to the developing opportunities of the market.

• Growing Demand for Hospitals and Clinics

The demand for hospitals and clinics is rising due to the rising number of piriformis syndrome patients which increases the number of treatments in the hospitals & clinics. This is the primary driver expected to boost the market's growth during the forecast period.

Opportunities

• Increase in the prevalence of diabetes

As per the reports of International Diabetes Federation (IDF), the adult diabetes population is around 537 million in 2021, and this number is increasing to 643 million in 2030. Several factors such as obesity, unhealthy diet, and physical inactivity are increasing the cases of Type 1 and Type 2 diabetes cases. The increasing occurrence of diabetic patients are the indication of the growing usage of meglitinides.

• Increase in Healthcare Expenditure

As per the statistics by the WHO, the global per capita healthcare expenditure amounted for this market is  USD 1,064.741 in the year 2017. The global healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. Thus, it creates much opportunity for the treatment of gangrene disease.

Restraints/Challenges

• High Cost of Gangrene Treatment

The high cost of treatment and the associated management is expected to act as a major limitation on the growth of the gangrene treatment medicines market.

• Unavailability of Appropriate Treatments

To treat conditions that are rare, many times, all treatments are not available, especially in the under-developed countries. The severe patient needs to be treated with advanced techniques but at times, these are not available in the hospitals and clinics. Thus, it hampers the market growth.

This global gangrene treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global gangrene treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Gangrene Treatment Market

Increasing transmission rates associated with previous COVID-19 strains and a reduction in vaccination effectiveness have made understanding the strain's impacts all the more important. Covid-19 sufferers are suffering from stomach pain, vomiting, loss of appetite, nausea, hearing loss, and joint pain. In the last two months, some patients have developed microthrombi, or minute blood clots, that have led the affected tissue to die and develop gangrene. As per the local media, doctors are also discovering clots increasing in blood veins that supply the intestines, causing patients to have stomach pain as their only symptom. Thus, COVID-19 had a major impact on the global gangrene treatment market.

Global Gangrene Treatment Market Scope

The gangrene treatment market is segmented on the basis of type, therapy type, treatment type, end-user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Dry Gangrene
• Wet Gangrene
• Internal Gangrene
• Others

Therapy Type

• Larval Debridement Therapy
• Hyperbaric Oxygen Therapy
• Others

治疗类型

• 药物
• 截肢
• 外科手术
• 其他的

给药途径

• 口服
• 注射剂
• 主题
• 其他的

最终用户

• 医院
• 家庭护理
• 专科诊所
• 其他的

分销渠道

• 医院药房
• 零售药店
• 网上药店
• 其他的

坏疽治疗市场区域分析/见解

对坏疽治疗市场进行了分析，并按类型、治疗类型、治疗类型、最终用户和分销渠道提供了市场规模洞察和趋势。

坏疽治疗市场报告涉及的主要国家 有：北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区（APAC）的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区（APAC）的其他地区、中东和非洲（MEA）的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于主要关键参与者的强劲表现，北美被认为在预测期内具有最高的利润增长。

由于口腔、鼻腔和嘴唇坏疽病例数量的增加，亚太地区在市场上占据主导地位。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和全球坏疽治疗市场份额分析

坏疽治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对坏疽治疗市场的关注有关。

全球坏疽治疗市场的主要参与者包括：

• F. Hoffmann-La Roche Ltd.（瑞士）

• Mylan NV（美国）
• Teva Pharmaceutical Industries Ltd.（以色列）
• 赛诺菲（法国）
• 辉瑞公司（美国）
• 葛兰素史克公司 (英国)
• 诺华公司（瑞士）
• 阿斯利康（英国）
• 强生私人有限公司（美国）
• 太阳制药工业有限公司 (印度)
• 默克公司（美国）
• 礼来（美国）
• 安进公司 (美国)
• 海南保利股份有限公司 (中国)
• WOCKHARDT（印度）

SKU-47981